FDA inspected Jagjivan Ram Hospital's blood bank operations and suspended its license due to regulatory violations.
1 report, 1 independent
Updated Jan 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA inspected Jagjivan Ram Hospital's blood bank operations and suspended its license due to regulatory violations.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
- A study author is based in Johns Hopkins School of Medicine, and the research is connected to Baltimore, now involving the FDA for drug approval.
- Sankalp, a business in Nagpur, faced license suspension and seizures after inspections by the FDA due to serious food safety violations.
- The FDA suspended licenses in Mumbai on September 1, 2026.
- FDA took food safety action, including license suspensions, across multiple cities in Maharashtra.